| |
| |
|
| Insider
Information: |
Dobmeier Eric |
| Relationship: |
President, CEO, Director |
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
730,812 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$28,097,365 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
730,812 |
|
|
| Total
Value |
$28,097,365 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
13
|
3
|
|
Stock
price went up :
|
7
|
3
|
| Stock
price went down : |
6
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.2
|
3.0
|
| Percentage
Gain/Loss : |
 18.2%
|
198.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
Chief Operating Officer |
2017-12-04 |
119,860 |
2004-05-05 |
0 |
Premium* |
|
|
Stemline Therapeutics Inc |
STML |
Director |
2017-06-19 |
27,963 |
|
0 |
Premium* |
|
|
Atara Biotherapeutics, Inc. |
ATRA |
|
2023-11-10 |
563,325 |
2015-12-16 |
0 |
Premium* |
|
|
Aravive Inc |
ARAV |
Director |
2017-12-20 |
18,160 |
2017-05-25 |
0 |
Premium* |
|
|
Adaptive Biotechnologies Corp |
ADPT |
Director |
2021-02-14 |
1,504 |
2019-12-26 |
0 |
Premium* |
|
|
Chinook Therapeutics Inc |
KDNY |
President, CEO, Director |
2023-08-11 |
0 |
2020-10-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
177 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
7,500 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • – |
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,960 |
6,960 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2017-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
12,500 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Director |
– • – |
2017-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
27,963 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2017-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
122,767 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2017-08-28 |
4 |
AS |
$47.89 |
$255,900 |
D/D |
(5,343) |
117,424 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2017-08-31 |
4 |
S |
$52.24 |
$1,305,893 |
D/D |
(25,000) |
117,424 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2017-08-31 |
4 |
OE |
$15.46 |
$386,500 |
D/D |
25,000 |
142,424 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2017-11-15 |
4 |
OE |
$15.46 |
$148,416 |
D/D |
9,600 |
127,024 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2017-11-15 |
4 |
S |
$57.80 |
$554,837 |
D/D |
(9,600) |
117,424 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2017-11-16 |
4 |
S |
$57.95 |
$892,637 |
D/D |
(15,400) |
117,424 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2017-11-16 |
4 |
OE |
$15.46 |
$311,617 |
D/D |
15,400 |
125,913 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2017-11-17 |
4 |
OE |
$26.10 |
$261,000 |
D/D |
10,000 |
127,424 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2017-11-17 |
4 |
S |
$59.13 |
$591,250 |
D/D |
(10,000) |
117,424 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2017-12-04 |
4 |
S |
$58.75 |
$219,092 |
D/D |
(3,729) |
117,424 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2017-12-04 |
4 |
OE |
$26.10 |
$197,300 |
D/D |
6,165 |
119,860 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • – |
2017-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
11,200 |
18,160 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2018-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
14,000 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2019-06-27 |
4 |
B |
$19.50 |
$39,000 |
D/D |
2,000 |
16,000 |
2.39 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2019-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
20,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2019-12-26 |
4 |
OE |
$6.32 |
$94,800 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2019-12-26 |
4 |
D |
$29.29 |
$439,351 |
D/D |
(15,000) |
0 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2019-12-26 |
4/A |
AS |
$29.29 |
$439,351 |
D/D |
(15,000) |
0 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2019-12-31 |
4/A |
AS |
$30.00 |
$150,000 |
D/D |
(5,000) |
0 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2019-12-31 |
4 |
D |
$30.00 |
$150,000 |
D/D |
(5,000) |
0 |
0 |
- |
|
177 Records found
|
|
Page 5 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
